Synnovis Group
- Company typePrivate
- Founded2021
- HeadquartersLondon, United Kingdom
- Headcount1,001–5,000
- GTM typeB2B
- OfferingServices
Synnovis Group firmographics
Firmographics- Name
- Synnovis Group
- Legal name
- Synnovis Group LLP
- Website
- https://synnovis.co.uk
- Company type
- Private
- Founded year
- 2021
- Operating status
- Operating
- Headcount range
- 1,001–5,000 employees
- Ownership category
- akta.pro rank
Synnovis Group industry classification
Industry- Product category
- Diagnostic Pathology Services
- NAICS
- Medical Laboratories (621511)
- SIC
- Services-Medical Laboratories (8071)
- akta.pro primary industry
- Central Laboratory Services (Core Lab Operations) (HLAGAEAA)
- akta.pro secondary industries
- Anatomic Pathology (Histopathology & Cytopathology) (HLAFAMAA), Microbiology & Infectious Disease Diagnostics (culture, rapid antigen, syndromic panels) (HLAAALAC)
Keywords
Where Synnovis Group is headquartered
LocationHeadquarters
- HQ city
- London
- HQ country
- United Kingdom
- HQ region
- Europe
Offices8 records
Markets served
Synnovis Group business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations
Revenue model
- NHS Pathology Services: Synnovis provides comprehensive pathology and diagnostic services to NHS trusts under long-term partnership agreements. The organization is jointly owned by SYNLAB UK & Ireland, Guy's and St Thomas' NHS Foundation Trust, and King's College Hospital NHS Foundation Trust.
- Specialist Diagnostic Testing: Provision of specialized diagnostic testing including liquid biopsy cancer testing, genomic analysis, and specialized reference laboratory services to NHS and private healthcare providers.
- Consumables Supply: Supply of pathology consumables including specimen collection kits and transportation bags to GP practices through an online ordering portal.
Go-to-market motion2 records
Distribution channels4 records
Marketing channels6 records
Synnovis Group product offering
Product offeringCore offering
Synnovis Group is the UK's leading pathology organization, operating as a joint venture between SYNLAB UK & Ireland, Guy's and St Thomas' NHS Foundation Trust, and King's College Hospital NHS Foundation Trust. The company delivers comprehensive diagnostic pathology services through a hub-and-spoke model centered at the Blackfriars Hub in London, processing 22.5 million tests annually across 60+ routine and specialist laboratories covering Blood Sciences, Haematology, Microbiology, Virology, Histopathology, Clinical Transplantation, Genetics, and Newborn Screening. Services are commissioned to NHS secondary care trusts, primary care GP practices, and private healthcare providers across South East London and beyond.
Product overview
Synnovis Group is the UK's leading pathology organisation operating as a joint venture between SYNLAB UK & Ireland, Guy's and St Thomas' NHS Foundation Trust, and King's College Hospital NHS Foundation Trust. Established in 2021 to transform pathology services in South East London, Synnovis delivers comprehensive diagnostic pathology services through a hub-and-spoke model centered at its state-of-the-art Blackfriars Hub facility. The company's portfolio includes AI-powered liquid biopsy testing via the MSK-ACCESS® partnership with SOPHiA GENETICS, advanced digital pathology technology, and over 60 routine and specialist laboratories covering Blood Sciences, Haematology, Clinical Biochemistry, Microbiology, Virology, Infection Sciences, Genetics, Histopathology, Clinical Transplantation, Haemostasis and Thrombosis, Diagnostic Immunology, Precision Medicine, and Newborn Screening. The Blackfriars Hub processes approximately 70% of the organisation's 22.5 million annual tests and serves nearly two million patients.
Differentiator
Problem solved
Functional benefit
Products and services
- MSK-ACCESS Liquid Biopsy Testing AI-powered blood-based diagnostic test that analyzes circulating tumor DNA from a simple blood draw to detect actionable genomic alterations for lung and breast cancer patients, enabling targeted therapy selection up to two weeks earlier. Offered under partnership with SOPHiA GENETICS using SOPHiA DDM AI platform.
- Virology Services Full specialist virology service including high-throughput molecular diagnostics, viral load testing, sequencing, genotyping, and antiviral resistance analysis for HIV, hepatitis viruses, respiratory viruses, and emerging pathogens. UKAS-accredited medical laboratory (No. 8640) to ISO 15189:2022.
- Haematology and Coagulation Services
- Clinical Biochemistry Services
- South East Haematological Malignancy Diagnostic Service (SE-HMDS)
- Precision Medicine Laboratory
- Regional Newborn Screening Laboratory
- Microbiology Services
- Clinical Transplantation Laboratory
- Diagnostic Immunology Laboratory
- Haemostasis and Thrombosis Services
- Histopathology Services
- Infection Sciences
- Drugs of Abuse Testing
Quantifiable outcome
- 22.5 million tests processed in past 12 months with volume doubling year on year
- +3 more outcomes
Companies that use Synnovis Group
Customer profileNamed customers8 records
Segments3 records
Ideal customer profiles3 records
Synnovis Group technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability2 records
Feature4 records
Synnovis Group partnerships and signals
Strategic signalPartnerships
Six partnerships are on record, tiered core and minor.
- SOPHiA GENETICScorePartnership to deliver MSK-ACCESS liquid biopsy testing (powered by SOPHiA DDM AI technology) for lung and breast cancer patients across the UK as part of NHS England's 'blood test-first' program. The blood-based test analyzes circulating tumor DNA from a simple blood draw and can help fast-track patients to targeted therapy up to two weeks earlier. Synnovis is already supporting approximately 400 patients per month and anticipates testing roughly 7,000 breast and lung cancer patients annually, representing about one-third of all ctDNA tests in England.
- Guy's and St Thomas' NHS Foundation TrustcoreJoint venture partner in Synnovis providing NHS pathology services. Synnovis operates as a pathology partnership between SYNLAB UK & Ireland, Guy's and St Thomas' NHS Foundation Trust, and King's College Hospital NHS Foundation Trust, established in 2021 to transform pathology services in South East London.
- King's College Hospital NHS Foundation TrustcoreJoint venture partner in Synnovis providing NHS pathology services. Synnovis operates as a pathology partnership between SYNLAB UK & Ireland, Guy's and St Thomas' NHS Foundation Trust, and King's College Hospital NHS Foundation Trust, established in 2021 to transform pathology services in South East London.
- SYNLAB UK & IrelandcoreParent company and joint venture partner controlling Synnovis operations. Synnovis is a pathology partnership between SYNLAB UK & Ireland, Guy's and St Thomas' NHS Foundation Trust, and King's College Hospital NHS Foundation Trust.
- Global Services Group (GSG)minorConsumables and logistics partner for Synnovis. GSG handles delivery of pathology consumables including specimen collection kits and transportation bags to GP practices. Orders are processed through the Synnovis online portal with delivery within 5 working days.
- BD (Becton Dickinson)minorPhlebotomy products supplier for Bexley, Greenwich and Lewisham GPs. BD handles ordering and delivery of phlebotomy supplies through dedicated email contacts.
Scale indicators12 records
Recent moves8 records
Expansion highlights5 records
Synnovis Group competitors and assessment
Company assessmentMarket position
Strengths4 records
Competitive moat5 records
Key risks5 records
Key highlights6 records
Customer concentration
Synnovis Group social profiles
Digital presenceSynnovis Group compliance and trust
Trust signalCompliance8 records
Synnovis Group financial estimates
Financial estimateRevenue estimate
Valuation estimate
Synnovis Group leadership team
Management profileNumber of profiles
Profiles5 records
Synnovis Group funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Synnovis Group M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Synnovis Group
What does Synnovis Group do?
Synnovis Group is the UK's leading pathology organization, operating as a joint venture between SYNLAB UK & Ireland, Guy's and St Thomas' NHS Foundation Trust, and King's College Hospital NHS Foundation Trust. The company delivers comprehensive diagnostic pathology services through a hub-and-spoke model centered at the Blackfriars Hub in London, processing 22.5 million tests annually across 60+ routine and specialist laboratories covering Blood Sciences, Haematology, Microbiology, Virology, Histopathology, Clinical Transplantation, Genetics, and Newborn Screening. Services are commissioned to NHS secondary care trusts, primary care GP practices, and private healthcare providers across South East London and beyond.
Is Synnovis Group a public or private company?
Synnovis Group is a private company. It is classified as corporate owned and is currently operating.
When was Synnovis Group founded?
Synnovis Group was founded in 2021. It employs 1,001 to 5,000 people.
Where is Synnovis Group based?
Synnovis Group is headquartered in London, United Kingdom, in the Europe region.
How does Synnovis Group make money?
Three revenue lines are on record. NHS Pathology Services are the primary driver. The others are specialist Diagnostic Testing and consumables Supply.
Does Synnovis Group have an API?
No public API is recorded for Synnovis Group.
What industry is Synnovis Group in?
Synnovis Group's product category is Diagnostic Pathology Services. Its primary akta.pro industry code is HLAGAEAA, Central Laboratory Services (Core Lab Operations), with a secondary code of HLAFAMAA, Anatomic Pathology (Histopathology & Cytopathology). Its NAICS code is 621511 and its SIC code is 8071.